Hakkini plans to recruit over 50 certified clinicians by end of 2026 as UAE demand for science-based mental healthcare ...

The occupational therapy profession got its start in 1917, when the United States War Department employed reconstruction aids ...

Pride Pediatric Therapy is proud to announce the upcoming opening of a new satellite clinic in Kingfield, Maine, scheduled ...

Medicare covers occupational therapy when the treatment is medically necessary. A person could receive covered services on an inpatient or outpatient basis. Some out-of-pocket costs and rules ...

Raising awareness of effective, evidence-based treatments — among hospitals, emergency department staff and patients — can vastly improve their outcomes. Medication for Opioid Use Disorder ...

How Much Does an Occupational Therapy Assistant Make? Occupational Therapy Assistants made a median salary of $67,010 in 2023. The best-paid 25% made $77,290 that year, while the lowest-paid 25% ...

While VR holds substantial theoretical promise, its integration into ADHD therapy must be grounded in rigorous empirical evidence—a point ... integration into clinical practice. In low-resource ...

However, these AI models are now becoming partners in care rather than simple tools for clinicians to utilize in their practice, he says ... similarly to the way we do when practicing evidence-based ...

The median overall survival from the date of progression was 12.19 months for patients who continued on pembrolizumab-based therapy and 4.44 months for patients who did not. Patients with ...

St Vincent's Hospital Cardiologist Professor Jason Kovacic questions “biohacks” such as cryotherapy, cold plunges, and red-light therapy, claiming there’s no “hard evidence to support that ...

The integration of technology into occupational therapy has become essential, particularly in response to the growing demand for remote services and evidence-based practices. Whether working with ...

This study provides valuable insights into the efficacy and safety of pyrotinib as an extended adjuvant therapy following trastuzumab-based treatment in patients with high-risk HER2-positive breast ...